Streptozotocin-induced alterations in rat liver golgi complexes are ameliorated by BMOV [bis(maltolato)oxovanadium(IV)] activity

Hormone and Metabolic Research

Volumn 36, Issue 3, 2004, Pages 148-154

  Kordowiak, A M ^a,b   Dziga, D ^b   Dabros W ^c  

^a Faculty of Biotechnology   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

BMOV; Galactosyltransferase; Phospholipids; Rat liver Golgi complexes; STZ diabetes; Vanadium

Indexed keywords

BIS(MALTOLATO)OXOVANADIUM; MALTOL; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; STREPTOZOCIN; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; ELECTRON MICROSCOPY; FEMALE; GOLGI COMPLEX; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GALACTOSYLTRANSFERASES; GOLGI APPARATUS; HYPOGLYCEMIC AGENTS; LIVER; MICROSCOPY, ELECTRON; OSMOLAR CONCENTRATION; PHOSPHOLIPIDS; PYRONES; RATS; RATS, WISTAR; SODIUM CHLORIDE; VANADATES; VANADIUM;

ANIMALIA;

EID: 1942537018     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814338     Document Type: Article

References (49)

1. Heyliger CE, Tahiliani AG, McNeill JH. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 1985; 227: 1474-1477
2. Reul BA, Amin SS, Buchet JP, Ongemba LN, Crans DC, Brichard SM. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats. Brit J Pharmacol 1999; 126: 467-477
3. Domingo JL. Vanadium and diabetes. What about vanadium toxicity? Mol Cell Biochem 2000; 203: 185-187
4. Poucheret P, Verma S, Grynpas MD, McNeill JH. Vanadium and diabetes. Mol Cell Biochem 1998; 188: 73-80
5. Cam MC, Brownsey RW, McNeill JH. Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent. Can J Physiol Pharmacol 2000; 78: 829-847
6. Crans DC. Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds. J Inorg Biochem 2000; 80: 123-131
7. Tsiani E, Fantus IG. Vanadium compounds. Biological actions and potential as pharmacological agents. Trends Endocrinol Metab 1997; 8: 51-58
8. Aharon Y, Mevorach M, Shamoon H. Vanadyl sulfate does not enhance insulin action in patients with type 1 diabetes. Diabetes Care 1998; 21: 2194-2195
9. Badmaev V, Prakash S, Majeed M. Vanadium: a review of its potential role in the fight against diabetes. J Alternat Complement Med 1999; 5: 273-291
10. Goldfine AB, Patti ME, Zuberi L, Goldstein BJ, LeBlanc R, Landaker EJ, Jiang ZY, Willsky GR, Kahn CR. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism 2000; 49: 400-410
11. Kaczmarski F, Kordowiak A, Sarnecka-Keller M. Influence of insulin on galactosyltransferase activity and morphology of the rat liver Golgi apparatus in control and streptozotocin-diabetic rats. Path Res Pract 1981; 172: 130-137
12. Kordowiak A, Turyna B, Kaczmarski F, Sarnecka-Keller M. Comparison of rat plasma glycoprotein composition with biochemical activity and morphology of liver Golgi apparatus in streptozotocin-diabetes treated with insulin. Folia Histochem Cytochem 1981; 19: 181-188
13. Kordowiak A. The phospholipid and cholesterol contents of Golgi-rich membrane fraction from streptozotocin- or alloxan-diabetic rats and 6 h after streptozotocin rat livers. Bull Acad Pol Sci 1984; 32: 165-171
14. 2) on streptozotocin-induced biochemical alterations of Golgi-rich membrane fraction in comparison with morphology of rat liver Golgi apparatus in situ. Path Res Pract 1986; 181: 397-402
15. Kordowiak AM. The phospholipid contents in rat liver Golgi-rich membrane fractions after streptozotocin and/or prostaglandin treatment. Folia Histochem Cytobiol 1986; 24: 39-46
16. Kordowiak AM, Polański M, Da̧broś W. Influence of LEPK on biochemical activity and morphology in situ of liver Golgi apparatus from control and streptozotocin-diabetic rats. Pol J Pathol 1997; 48: 87-93
17. Da̧broś W, Kordowiak AM, Dziga D, Gryboś R. Influence of bis(maltolato) oxovanadium(IV) on activity of galactosyltransferase (GalT) and morphology of rat liver Golgi apparatus in control and streptozotocin diabetes. Pol J Pathol 1998; 49: 67-76
18. Da̧broś W, Dziga D, Gryboś R, Kordowiak AM. Biochemical and morphological alterations in rat liver Golgi complexes after treatment with bis(maltolato)oxovanadium(IV) [BMOV] or maltol alone. Path Res Pract 2000; 196: 561-568
19. Da̧broś W, Dziga D, Kordowiak AM. The influence of BMOV[bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations, characteristic for streptozotocin-diabetic rat liver Golgi complexes. Pol J Pathol 2002; 53: 205-213
20. 2O. Part I. One-week treatment with vanadium compound. Pol J Pathol 2000; 1: 9-16
21. Kordowiak AM, Trzos R, Gryboś R. Insulin-like effects on liver Golgi membrane preparations of bis(oxalato)oxovanadate(IV) complex ion, a new vanadium compound. Horm Metab Res 1997; 29: 104-108
22. Kordowiak AM, Dudek B, Gryboś R. Influence of sodium(oxalato) oxovanadium(IV) on phospholipids in liver Golgi fractions from control and streptozotocin-diabetic rats. Comp Biochem Physiol Part C 2000; 125: 11-16
23. Kordowiak AM, Da̧broś W, Kajda B. The influence of a new vanadium compound, bis(2,2′-bipyridine)oxovanadium(IV) sulphate on liver Golgi complexes from control and streptozotocin-diabetic rats. Horm Metab Res 2002; 34: 1-5
24. Yuen VG, Caravan P, Gelmini L, Glover N, McNeill JH, Setyawati IA, Zhou R, Orvig C. Glucose lowering properties of vanadium compounds. Comparison of coordination complexes with maltol or kojic acid as ligands. J Inorg Biochem 1997; 68: 108-116
25. Fleischer B. Isolation and characterisation of Golgi apparatus from rat liver. In: Fleischer S, Packer L. (eds). Methods in Enzymology Vol 31A New York: Acad Press Inc, 1974: 180-191
26. Lowry OH, Rosebrough NJ, Farr A-L, Randall R-J. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-275
27. Somogyi MJ, Nelson N. Determination of reducing sugars and carbohydrates. In: Whistler R, Wolprom R. (eds). Methods in Carbohydrate Chemistry vol 1 New York, London: Acad Press Inc, 1962: 380-394
28. Kates M. Techniques of lipidology. Isolation, analysis and identification of lipids. In: Work TS, Work E. (eds). Laboratory Techniques in Biochemistry and Molecular Biology vol.3 New York: Elsevier, 1972: 267-502
29. Vaskovsky VE, Kostetsky EY, Vasendin IM. A universal reagent for phospholipid analysis. J Chromatogr 1975; 114: 129-141
30. Karnovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J Cell Biol 1965; 27: 137A-138A
31. Venable JH, Coggeshall RA. Simplified lead citrate stain for use in electron microscopy. J Cell Biol 1965; 25: 407-408
32. Marzban L, Bhanot S, McNeill JH. In vivo effects of insulin and bis(maltolato)oxovanadium(IV) in PKB activity in the skeletal muscle and liver of diabetic rats. Mol Cell Biochem 2001; 223: 147-157
33. Wang J, Yuen VG, McNeill JH. Effect of vanadium on insulin sensitivity and appetite. Metabolism 2001; 50: 667-673
34. Cam MC, Brownsey RW, Rodrigues B, McNeill JH. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin- diabetic rats. Metabolism 2001; 50: 674-680
35. y mice. J Inorg Biochem 2002; 88: 108-112
36. Semiz S, Orvig C, McNeill JH. Effects of diabetes, vanadium and insulin on glycogen synthase activation in Wistar rats. Mol Cell Biochem 2002; 231: 23-35
37. Mohammad A, Wang J, McNeill JH. Bis(maltolato)oxovanadium(IV) inhibit the activity of PTP1B in Zucker rat skeletal muscle in vivo. Mol Cell Biochem 2002; 229: 125-128
38. Mohammad A, Bhanot S, McNeill JH. In vivo effects of vanadium in diabetic rats are in dependent of changes in PI-3 kinase activity in skeletal muscle. Mol Cell Biochem 2001; 223: 103-108
39. Thompson KH, Tsakuda Y, Xu Z, Battell M, McNeill JH, Orvig C. Influence of chelation and oxidation state on vanadium bioavailability anf their effects on tissue concentrations of zinc, cooper and iron. Biological Trace Element Research 2002; 86: 31-44 Humana Press Inc.
40. Rehder D, Pessoa JC, Geraldes CFGC, Castromm CA, Kabanos T, Kiss T, Meier B, Micera G, Petterson L, Rangel M, Salifoglou A, Turel I, Wand D. In vitro study of the insulin-mimetic behaviour of vanadium(IV,V) coordination compounds. J Biol Inorg Chem 2002; 7: 384-396
41. Shafrir E, Spielman S, Nachliel I, Khamaisi M, Bar-On H, Ziv E. Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil. Diabetes Metab Res Rev 2001; 17: 55-66
42. Woo LCY, Yuen VG, Thompson KH. Vanadyl-biquanide complexes as potential synergistic insulin mimics. J Inorg Biochem 1999; 76: 251-257
43. Kordowiak A, Sarnecka-Keller M. The protein patterns of Golgi-rich membrane preparations from the livers of control, insulin treated and streptozotocin diabetic rats. Bull Acad Pol Sci 1977; 25: 205-209
44. Roth MG, Bi K, Ktistakis NT, Yu S. Phospholipase D as an effector for ADP-ribosylation factor in the regulation of vesicular traffic. Chem Phys Lipids 1999; 98: 141-152
45. De Camili P, Emr SD, McPherson PS, Novick P. Phosphoinositides as regulators in membrane traffic. Science 1996; 271: 1533-1539
46. Breton C, Mucha J, Jeanneau C. Structural and functional features of glycosyltransferases. Biochimie 2001; 83: 713-718
47. Kordowiak AM, Wojas J, Subczyński WK. Fluidity of rat liver Golgi membranes in streptozotocin diabetes. A spin label study. Biochem Biophys Acta 1990; 1022: 296-302
48. Siddhanta A, Shields D. Secretory vesicle budding from the trans-Golgi network is mediated by phosphatidic acid levels. J Biol Chem 1998; 273: 17995-17998
49. Siddhanta A, Bacek JM, Shields D. Inhibition of phosphatidic acid synthesis alters the structure of the Golgi apparatus and inhibits secretion of endocrine cells. J Biol Chem 2000; 275: 12023-12031